Oracle Corporation's Upcoming Earnings Report: A Detailed Analysis

Posted Mar 7 by John Deo

Oracle Corporation (NYSE:ORCL) is a leading technology company known for its comprehensive suite of cloud appl

Source: Two Blokes Trading

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Financial Performance and Competitive Landscape

Posted Mar 7 by John Deo

Avadel Pharmaceuticals plc (NASDAQ:AVDL) has a Return on Invested Capital (ROIC) of -36.37% and a Weighted Av

Source: Two Blokes Trading

State Street Corporation's Financial Performance and Capital Utilization Compared to Peers

Posted Mar 7 by John Deo

State Street Corporation (NYSE:STT) has a Return on Invested Capital (ROIC) of 0.55% and a Weighted Average C

Source: Two Blokes Trading

SOPHiA GENETICS SA (NASDAQ:SOPH) Financial Analysis

Posted Mar 7 by John Deo

SOPH's Return on Invested Capital (ROIC) is -52.00%, indicating it is not generating sufficient returns to co

Source: Two Blokes Trading

DarioHealth Corp. (NASDAQ:DRIO) Earnings Preview: A Deep Dive into Financial Health and Market Position

Posted Mar 7 by John Deo

Anticipated quarterly loss of $0.16 per share with projected revenue of $7.39 million. Negative P/E ratio of

Source: Two Blokes Trading

KVH Industries, Inc. (NASDAQ: KVHI) Earnings Report Highlights

Posted Mar 7 by John Deo

Earnings per Share (EPS) fell short at -$0.22 compared to the estimated -$0.07. Total revenues decreased by 1

Source: Two Blokes Trading

Merck KGaA's Financial Overview and Market Position

Posted Mar 7 by John Deo

Merck KGaA (PNK:MKGAF) reported earnings per share of $2.14, missing estimates. The company's revenue was $5.

Source: Two Blokes Trading

Tivic Health Systems, Inc. (NASDAQ:TIVC) Executes Reverse Stock Split

Posted Mar 7 by John Deo

Tivic Health Systems, Inc. (NASDAQ:TIVC) has conducted a reverse stock split at a ratio of 17 for 1 to meet N

Source: Two Blokes Trading

Aytu BioPharma, Inc. (NASDAQ:AYTU) and Its Competitive Landscape

Posted Mar 7 by John Deo

Aytu BioPharma's Return on Invested Capital (ROIC) is -18.15%, indicating inefficiency in using capital to ge

Source: Two Blokes Trading

Theriva Biologics, Inc. (AMEX:TOVX) Financial Analysis and Peer Comparison

Posted Mar 7 by John Deo

Theriva Biologics, Inc. (AMEX:TOVX) is a biotechnology company focused on developing innovative therapies for

Source: Two Blokes Trading

Neuronetics, Inc. (NASDAQ:STIM) Financial Efficiency Analysis

Posted Mar 7 by John Deo

Neuronetics, Inc. (NASDAQ:STIM) is a leading medical technology company that specializes in developing non-inv

Source: Two Blokes Trading

VersaBank's Financial Performance and Market Position

Posted Mar 6 by John Deo

Earnings Per Share (EPS) of $0.19 was reported, falling below the expected $0.29, marking a significant earni

Source: Two Blokes Trading